Dr. Lalchandani Labs Ltd.BSE: DLCL

Dr. Lalchandani Labs Ltd. Press Release Aug 25 2025

· Issued by Dr. Lalchandani Labs Ltd. via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/dr-lalchandani-labs-ltd-press-release-aug-25-2025

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani

View Attachment

6ix hasn’t read this filing yet.

Dr. Lalchandani Labs Ltd. on 6ix

Earlier from Dr. Lalchandani Labs

Later from Dr. Lalchandani Labs

All Dr. Lalchandani Labs news releases